infectious disease – Page 3

‘Preprints are works in progress’: The tale of a disappearing COVID-19 paper

When a Twitter user tipped us off last week to the mysterious disappearance of a preprint of a paper on a potential new therapy to treat Covid-19, we were curious. Was it a hidden retraction, or something else?

The article, titled “Effectiveness of ZYESAMI™ (Aviptadil) in Accelerating Recovery and Shortening Hospitalization in Critically-Ill Patients with COVID-19 Respiratory Failure: Interim Report from a Phase 2B/3 Multicenter Trial,” had popped up on SSRN on April 1.

The trial was funded by NeuroRX, the maker of Zyesami, which trumpeted the results in a series of press releases dating back to February 2021. NeuroRX has been partnering with Relief Therapeutics on the development of the drug, but that marriage seems to be rather rocky.

Guillaume Cabanac, a computer scientist in France, tweeted that by May 10 the paper had vanished with only a trace of meta-data. As another Twitter user noted, however, the article had reappeared on the preprint server with a different title. (We see the post date on SSRN as May 11.)

We took a look at the two articles and found some interesting differences.

Widely shared vitamin D-COVID-19 preprint removed from Lancet server

A preprint promoted by a member of the UK Parliament for claiming to show that vitamin D led to an “80% reduction in need for ICU and a 60% reduction in deaths” has been removed from a server used by The Lancet family of journals.

The preprint, “Calcifediol Treatment and COVID-19-Related Outcomes,” was posted to Preprints with The Lancet on January 22. On February 13, David Davis, a Conservative member of UK’s Parliament, tweeted:

Medical writer loses COVID-19-cancer paper for plagiarism

An oncology journal has retracted a review article on the hypothetical link between Covid-19 and cancer after determining that the medical writer who authored the work hadn’t done all the writing herself.

The paper, “Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer?” appeared in Future Oncology in May and was written by Priya Hays, who at the time was a technical writer with Talis Biomedical Corp., in Menlo Park, Calif. Hays is currently with Abbott, according to her LinkedIn profile. She also has a company called Hays Documentation Specialists, which offers a variety of manuscript services, including academic writing and something called “unstructured authoring assistance.”

As the retraction notice indicates, Hays appears to have had some authoring assistance of her own:

Public health journal “seeking further expert advice” on January paper about COVID-19 PCR testing by high-profile virologist

After a petition from nearly two dozen people in Europe, the United States and Asia, a public health journal says it is investigating an article it published last January about a way to detect the virus that causes COVID-19.

[Please see an update on this post.]

The paper, “Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR,” appeared in Eurosurveillance. It was received on January 21 and accepted on January 22, a remarkably quick turnaround under normal circumstances, although not unheard of during the pandemic. It has been cited well over 800 times, according to Clarivate Analytics’ Web of Science.

The senior author of the work was Christian Drosten, of the Charité University Hospital in Berlin, who became something of a celebrity virologist — the Anthony Fauci of Germany — in the early days of the pandemic. As Science reported in late April, Drosten’s podcast, Coronavirus Update, became the most popular podcast in Germany, garnering more than 1 million downloads per episode.

Johns Hopkins student newspaper deletes, then retracts, article on faculty member’s presentation about COVID-19 deaths

A student newspaper at Johns Hopkins has retracted an article claiming that COVID-19 has had “relatively no effect on deaths in the United States.”

The article, “A closer look at U.S. deaths due to COVID-19” (link from the Wayback Machine) was published on November 22 and relied on a presentation by Genevieve Briand, assistant program director of the Applied Economics master’s degree program at Hopkins.

From the article:

Amulets may prevent COVID-19, says a paper in Elsevier journal. (They don’t.)

Sometimes, we just don’t know what to say.

So we’ll let the people of Twitter comment on a paper titled “Can Traditional Chinese Medicine provide insights into controlling the COVID-19 pandemic: Serpentinization-induced lithospheric long-wavelength magnetic anomalies in Proterozoic bedrocks in a weakened geomagnetic field mediate the aberrant transformation of biogenic molecules in COVID-19 via magnetic catalysis,” claiming that

Widely cited COVID-19-masks paper under scrutiny for inaccurate stat

You probably read a story or heard a news report over the past few days saying that if nearly all Americans wore masks to prevent COVID-19 spread, 130,000 lives could be saved by the end of February. That’s what a paper published on Friday says.

But it turns out that figure sounds twice as good as reality. Here’s the story:

On October 6, a group at the Institute for Health Metrics Evaluation (IHME) — a frequently cited source of COVID-19 data — submitted a manuscript to Nature Medicine. The paper was accepted on October 13, and published on October 23. It concluded:

The list of retracted COVID-19 papers is up to 33

To the list of COVID-19 papers that have been retracted so far, add this:

The Korean Journal of Anesthesiology has retracted an article it published last month on ventilating COVID patients because it was nearly identical to one that had appeared in a different journal three months earlier.

The offending article, “Noninvasive versus invasive ventilation: one modality cannot fit all during COVID-19 outbreak,” was written by Abhishek Singh, an anesthesiologist at the All India Institute of Medical Sciences in New Delhi.

Going cold turkey: Infectious disease-poultry researcher up to 14 retractions

Nine strikes in a row in bowling is called a “golden turkey.” So what do you call 10 papers on poultry pulled at once for plagiarism?

We first wrote about Sajid Umar in July 2018, when he’d lost a 2016 article in Scientifica for plagiarism and other sins, and then again earlier this summer when he notched two more retractions from Poultry Science for “grave mistakes.”

Now, the World’s Poultry Science Journal, a Taylor & Francis title, has pulled 10 more of Umar’s articles — bringing his total to 14, by our count. According to the retraction notice for the 2017 paper “Mycoplasmosis in poultry: update on diagnosis and preventive measures”:

Hydroxychloroquine, push-scooters, and COVID-19: A journal gets stung, and swiftly retracts

This may be the scientific publishing version of “the operation was a success, but the patient died.”

The retraction of a Trojan horse paper on the novel coronavirus has called into question the validity of another article in the same journal which found that hydroxychloroquine is effective against Covid-19.

The sting article, “SARS-CoV-2 was Unexpectedly Deadlier than Push-scooters: Could Hydroxychloroquine be the Unique Solution?” — was the brainchild of graduate student Mathieu Rebeaud, aka “Willard Oodendijk” and Florian Cova, of “The Institute for Quick and Dirty Science” (no, not really) in Switzerland. Their goal: to highlight a concerning paper in the Asian Journal of Medicine and Health, which they and others suspect of being a predatory publication — one that is happy to take money to publish anything, while pretending to perform peer review.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: